WTA
CGON icon

Washington Trust Advisors’s CG Oncology CGON Stock Holding History

Washington Trust Advisors’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-49
Closed -$1.97K – 606
2025
Q3 		$1.97K Hold
49
– – ﹤0.01% 661
2025
Q2 		$1.27K Hold
49
– – ﹤0.01% 620
2025
Q1 		$1.2K Hold
49
– – ﹤0.01% 624
2024
Q4 		$1.41K Hold
49
– – ﹤0.01% 633
2024
Q3 		$1.85K Hold
49
– – ﹤0.01% 639
2024
Q2 		$1.55K Hold
49
– – ﹤0.01% 640
2024
Q1 		$2.15K Buy
+49
New +$2K ﹤0.01% 638

Other funds holding CGON

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Washington Trust Advisors's CGON Position: Q4 2025 in Review

Washington Trust Advisors sold out of CG Oncology (CGON) in Q4 2025, closing a stake of 49 shares — an estimated $1.97K sold.

Washington Trust Advisors first reported a position in CGON in Q1 2024 and held it in 7 quarters. The position peaked at $2.15K in Q1 2024. 195 funds tracked by Wall St. Rank hold CGON as of Q4 2025.

  • Washington Trust Advisors reported no remaining CG Oncology position as of Q4 2025 after selling out during the quarter.
  • Washington Trust Advisors sold 49 CG Oncology shares in Q4 2025, an estimated $1.97K.
  • Washington Trust Advisors first reported a position in CG Oncology in Q1 2024 and held it in 7 quarters.
  • Washington Trust Advisors's CG Oncology position peaked at $2.15K in Q1 2024.
  • 195 funds tracked by Wall St. Rank held CG Oncology as of Q4 2025.

Based on Washington Trust Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.